HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm Now, Securities Fraud Action PendingNewsfile Corp • 06/18/21
ROSEN, SKILLED INVESTOR COUNSEL Encourages ChemoCentryx, Inc. Investors to Secure Counsel Before Important July 6 Deadline in Securities Class Action - CCXINewsfile Corp • 06/17/21
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 06/17/21
INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 06/16/21
ChemoCentryx to Participate in the Raymond James 2021 Human Health Innovations ConferenceGlobeNewsWire • 06/16/21
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 06/15/21
HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors to Contact the Firm Now, Securities Fraud Action PendingNewsfile Corp • 06/14/21
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 06/14/21
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)PRNewsWire • 06/11/21
Rosen, Globally Respected Investor Counsel, Encourages ChemoCentryx, Inc. Investors to Secure Counsel Before Important July 6 Deadline in Securities Class Action with Expanded Class Period - CCXINewsfile Corp • 06/11/21
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.PRNewsWire • 06/11/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts ChemoCentryx (CCXI) Investors to EXPANDED FRAUDULENT PERIOD in Securities Fraud Action: Investors Should Secure CounselPRNewsWire • 06/10/21
Scott+Scott Attorneys at Law LLP Reminds Investors to Securities Class Action Against ChemoCentryx, Inc. (CCXI) and July 6 DeadlineBusiness Wire • 06/09/21
ChemoCentryx Announces Abstract on Avacopan in ANCA-Associated Vasculitis Selected as One of the Ten Best Abstracts at the ERA-EDTA CongressGlobeNewsWire • 06/08/21
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for ChemoCentryx, Inc. InvestorsNewsfile Corp • 06/07/21
SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.PRNewsWire • 06/05/21
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages ChemoCentryx, Inc. Investors to Secure Counsel Before Important July 6 Deadline in Securities Class Action - CCXIPRNewsWire • 06/05/21
HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors with Losses to Contact its Attorneys, Securities Class Action PendingNewsfile Corp • 06/04/21
LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the FirmNewsfile Corp • 06/03/21
CCXI Breaking Notice: Rosen, A Leading Investor Rights Law Firm, Encourages ChemoCentryx, Inc. Investors with Losses to Secure Counsel Before Important Deadline - CCXINewsfile Corp • 06/02/21
Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds ChemoCentryx, Inc. Investors of Securities Fraud Class Action LawsuitNewsfile Corp • 06/02/21
HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm Now, Securities Fraud Lawsuit PendingNewsfile Corp • 06/01/21
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages ChemoCentryx, Inc. Investors with Losses to Secure Counsel Before Important Deadline – CCXIBusiness Wire • 05/30/21